The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with ...

A technique that combines super-resolution microscopy with advanced computational analysis could identify early signs of Parkinson’s disease ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

Advanced 'Parkinson's in a Dish' Model Accelerates Brain Disease Research July 29, 2024 — Researchers have developed a model that rapidly converts stem cells to brain cells with protein ...

Brain disorders like Parkinson’s or Alzheimer’s Disease start to develop in patients much earlier than when their first ...

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

We are excited about what this fiscal year has to offer as we started by reporting promising data from our Phase 2 clinical trial in ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced ...